Vol9_n2_Oct07 - SoMaMFyC
Vol9_n2_Oct07 - SoMaMFyC
Vol9_n2_Oct07 - SoMaMFyC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
REVISIóN TERApEÚTICA<br />
bIbLIOgRAFíA<br />
NUEVOS TRATAMIENTOS DE LA OSTEOPOROSIS POSMENOPÁUSICA<br />
1. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993; 94(6):646-50.<br />
2. NIH Consensus Development on Osteoporosis Prevention DaT. Osteoporosis prevention, diagnosis and therapy. JAMA 2001; 285:785-<br />
95.<br />
3. Melton LJ 3rd. How many women have osteoporosis now? J Bone Miner Res 1995; 10(2):175-7.<br />
4. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9(8):1137-<br />
41.<br />
5. Diaz Curiel M. Prevalencia de la osteopoprosis determinada por densitometría en la población femenina espa_ola. Med Clin (Barc) 2001;<br />
116:86-8.<br />
6. Diaz Curiel M. Prevalencia de la osteoporosis densitométrica en la población femenina espa_ola. Madrid : FHOEMO-SEIOMM-RPR.<br />
Rhone Poulec, 1996.<br />
7. Looker AC, Orwoll ES, Johnston CC Jr et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner<br />
Res 1997; 12(11):1761-8.<br />
8. Iki M, Kagamimori S, Kagawa Y, Matsuzaki T, Yoneshima H, Marumo F. Bone mineral density of the spine, hip and distal forearm in representative<br />
samples of the Japanese female population: Japanese Population-Based Osteoporosis (JPOS) Study. Osteoporos Int 2001;<br />
12(7):529-37.<br />
9. Torgerson DJ, Reid DM. The economics of osteoporosis and its prevention. A review. Pharmacoeconomics 1997; 11(2):126-38.<br />
10. Figueroa Pedrosa M.M. Teriparatida (1-34 hormona paratiroidea recombinante humana): un potente agente constructor de hueso para el<br />
tratamiento de la osteoporosis. Rev Esp Reum 2004; 3(1): 1-3<br />
11. Armas Ramírez de Verger C. Mecanismo de acción de la hormona paratifoidea. Rev Esp Reum 2004; 3(1): 12-18<br />
12. Neer RM, Arnaud CD, Zanchetta JR et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal<br />
women with osteoporosis. N Engl J Med 2001; 344(19):1434-41.<br />
13. Marcus, R.; Wang, O.; Satterwhite, J., and Mitlak, B. The skeletal response to teriparatide is largely independent of age, initial bone mineral<br />
density, and prevalent vertebral fractures in postmenopausal women with osteoporosis. J Bone Miner Res. 2003 Jan; 18(1):18-23.<br />
14. Peris P. Toxicidad de la teriparatide. Rev Esp Reum 2004; 3(1): 19-23<br />
15. Hernández Rodríguez I. Formación de hueso de calidad. Histomorfometría y biomecánica del hueso tratado con teriparatida. Rev Esp<br />
Reum 2004; 3(1): 24-33<br />
41